We evaluate a new assay reagent for lipase determination, based on the use of 1,2-o-dilauryl-rac-glycero-3-glutaric acid±(6'-methylresoru®n) ester (DGGR) as substrate. DGGR is cleaved by lipase, resulting in an unstable dicarbonic acid ester which is spontaneously hydrolysed to yield glutaric acid and methylresoru®n, a bluish-purple chromophore with peak absorption at 580 nm. The rate of methylresoru®n formation is directly proportional to the lipase activity in the sample. Bile salts, colipase and calcium chloride are included to provide optimal reactivity and speci®city. Analysis of total imprecision gave a coef®cient of variation of between 5´7% and 9´6%. Anticoagulants, common interfering substances and carboxylesterase had no effect on the assay, but interference by increased concentrations of serum triglycerides was noted. Good correlations were obtained with turbidimetry and a coupled enzymatic method. The estimated reference interval was 6±38 U/L. The unique characteristics of the chromogenic substrate qualify the present method as an innovative approach to serum lipase analysis.
INTRODUCTION
The determination of pancreatic lipase catalytic activity (EC 3.1.1.3) in serum is now well established in the diagnosis and monitoring of acute pancreatitis 1±3 and it is generally regarded as providing superior clinical speci®city to the determination of amylase. 4, 5 However, the test is not as popular as the measurement of serum amylase in clinical laboratories, mainly for methodological reasons. Although optimal concentrations of colipase, bile salts and calcium ions have been introduced in almost all of the commercially available reagents, most assays still show various analytical problems: long analysis time, non-speci®city of the substrate used, or dif®culties related to standardization and between-method discrepancies. 6, 7 Methods for lipase activity determination can be categorized into those that measure a decrease in substrate (e.g. turbidimetry) and those that measure an increase in product (e.g. titrimetric and coupled enzymatic methods). 3 Despite widespread acceptance, some analytical drawbacks (lot-to-lot variability in substrate emulsion and composition, narrow measuring range and low sensitivity in the subnormal range, with negative activities in some specimens) signi®cantly limit the reliability of turbidimetric measurement. 8 Titrimetric assays, which have also been described as the method of choice for lipase, 9 are labour-intensive, time-consuming, dif®cult to automate and require specialized equipment. Coupled enzymatic methods utilize a series of enzymatic steps to generate an easily measured product such as glycerol. 10±13 With few exceptions, these enzyme coupling procedures are usually carried out in the presence of diglycerides to increase substrate solubility in water; however, although they are precise and simple to perform, these methods can be subject to interference by non-pancreatic lipases. 14±16 In this study, we evaluate a method for pancreatic lipase determination in serum or plasma using a kinetic colorimetric approach based on chromogenic substrate technology. The substrate is 1,2-o-dilauryl-rac-glycero-3-glutaric acid±(6'-methylresoru®n) ester (DGGR), which has been synthesized and patented by Roche Diagnostics.
PRINCIPLE
The proposed assay is based on the use of DGGR as substrate for pancreatic lipase activity. This glycerol-derived compound is cleaved by the enzyme, resulting in an unstable dicarbonic acid ester which is spontaneously hydrolysed under alkaline pH to yield glutaric acid and methyl-resoru®n, a bluish-purple chromophore with peak absorption at 580 nm. The rate of methyl-resoru®n formation is directly proportional to the lipase activity in the sample. The reaction sequence is as follows:
DGGR lipase
Glutaric acid-6 ¢ -methylresorufin ester water -® Glutaric acid + methylresorufin
MATERIALS AND METHODS

Apparatus
We used a double-beam spectrophotometer with a temperature-controlled cuvette holder (Lambda 2; Perkin-Elmer Corp.) to assess absorption spectra, the molar absorptivity of the dye and reaction kinetics. In studies exploring the potential for automating the assay and in the following evaluation, we used a Cobas-Bio centrifugal analyser (Roche Diagnostics). Comparison methods (turbidimetry and coupled enzymatic method) were also performed using the Cobas-Bio analyser.
Materials
Methylresoru®n was obtained from Roche Diagnostics. Puri®ed human pancreatic lipase preparation was obtained from Calbiochem Corp. Carboxylesterase (EC 3.1.1.1) from rabbit liver was obtained from Sigma Chemical Co. Control materials were commercially available serum samples from several sources. The reagent kit for the evaluated lipase assay (Lipase Color Liquid, product no. 17401) was a gift from Sentinel Diagnostics. The kit, which was not commercially available at the time of the study, provides two`ready-to-use' liquid solutions. Solution 1 contains, per litre of Tris buffer (41 mmol/L, pH 8´4 at 258C), 1 mg of colipase, 1´8 mmol of sodium deoxycholate and 7´2 mmol of sodium taurodeoxycholate; the solution also contains preservatives and is stable for at least 6 months at 2±88C. Solution 2 contains, per litre of tartrate buffer (1´6 mmol/L, pH 4´0 at 258C), 0´24 mmol of DGGR, 0´1 mmol of calcium chloride, detergents and preservatives; stored at 2±88C, the solution is stable for 6 months. Information on the exact type and concentrations of detergents and preservatives included in the kit assay was not available from the manufacturer. Solution 2 is adjusted to an acidic pH for better dissolution of the substrate microemulsion; solution 1 is made slightly alkaline to ensure optimal pH of its ®nal mix with solution 2. A clear solution is obtained when solutions 1 and 2 are mixed and the ®nal reaction takes place in a buffered medium adjusted to pH 8´3 at 378C, which is optimal both for the activity of human serum pancreatic lipase in the presence of colipase, bile salts and calcium ions, and for the spontaneous hydrolysis of the unstable glutaric acid-6'-methylresoru®n ester.
Procedures
Lipase activity was measured by rate assay at 378C. For the manual assay, 10 mL of sample or distilled water (for the reagent blank) was mixed with 1´5 mL of solution 1 and 150 mL of solution 2. After a 1-min lag phase, the absorbance change per minute was monitored at 580 nm for the sample versus the reagent blank. To automate the assay, the above procedure was applied to the Cobas-Bio analyser. The absorbance changes at 580 nm were monitored for the sample versus the reagent blank for 120 s after a 60-s lag phase which followed a 10-s incubation of the sample with solution 1. The molar absorptivity utilized for the methylresoru®n derived from DGGR was 62 300 L/mol/cm at 580 nm. Lipase activity was expressed as U/L (mmoles of substrate converted per minute per litre under the speci®ed conditions).
For inter-method comparisons, serum lipase was measured by turbidimetry at 308C, using a commercially available test kit from Roche Diagnostics, 17 and by a coupled enzymatic assay at 378C, according to the method described by Panteghini et al. 13 
Reference population
To establish the reference interval for lipase activity in serum, we studied 162 apparently healthy people (85 women and 77 men, aged 16±85 years) with normal serum biochemical and haematological test results and without clinical evidence of abdominal disease.
RESULTS
Dye molar absorptivity
The molar absorptivity of the methylresoru®n was measured in the buffered working solution (solution 1 plus solution 2) both with and without the serum matrix. Peak dye absorption occurs at 580 nm. The molar absorptivity of the dye was unaffected by the addition of matrix, remaining at 62 300 mol/L/cm at the 378C assay temperature (mean value of three different determinations). Additional experiments at 308C showed no signi®cant changes of molar absorptivity attributable to temperature.
Reaction kinetics
To explore the reaction rates at 378C, we assayed several human serum samples (normal and high in lipase). Investigation of the effect of the lag time on the linearity of the enzymatic reaction showed that adequate steady-state (constant rate) measurements were obtained after a lag phase of 60 s. Zero-order kinetics were maintained for 54 min after the lag phase. The spontaneous hydrolysis of DGGR (overall reaction mixture but with water instead of the sample) was minimal ( A/min50´010).
Linearity range
Under the conditions described, the products of the reaction increased linearly with serum lipase concentrations up to 200 U/L ( A/min=0´100). Pooled lipase-rich specimens were diluted serially with reagent-gradewater. Four separate dilutions were assayed and each dilution was run in duplicate. The curve obtained showed no signi®cant curvature when tested for linearity as suggested by Burnett 18 (quadratic regression: y=0´30+151´2x71´962x 2 , with the coef®cient of x 2 not signi®cantly different from 0; P=0´92). Linear regression analysis of these data [y= 148´9( 2´6)x+0´7( 1´5); standard error of estimate=1´8] con®rmed the high linearity of the response (r=0´9997). The minimum detectable lipase activity, as assessed by ten replicate measurements of a heat-inactivated serum in a single run and de®ned as the lipase value corresponding to a signal three standard deviations (3 SD) greater than the mean found for this serum sample, was estimated as 5 U/L.
Imprecision
The method of estimating imprecision was the analysis of variance experiment described in the NCCLS EP5-A document, and included two replicates per specimen per run and one run per day for 20 days. 19 Three serum samples with normal, increased and markedly above-normal lipase activities were used; the serum samples were stored at 7258C between each experiment. Results are shown in Table 1 .
Recovery and interference studies
Analyses of scalar amounts of puri®ed human pancreatic lipase added to a serum sample showed an average relative recovery of 102´1% (%CV=2´5). Anticoagulants such as EDTA dipotassium salt (2´5 mmol/L), sodium citrate (20 mmol/L) and lithium heparin (1 g/L) as well as sodium¯uoride (50 mmol/L), an inhibitor of glycolysis, had no effect on the evaluated assay. Reducing substances such as ascorbic acid, glucose, creatinine and uric acid did not interfere up to values of 200 mg/L, 10 g/L, 500 mg/L and 200 mg/L, respectively. We also found no in¯uence from bilirubin (4400 mg/L), haemoglobin(44 g/L), free glycerol (4500 mg/L) or rheumatoid factor [4550 kU/L, determined using a rate-nephelometric latex method (Dade Behring)]. Conversely, the method was susceptible to negative interference by increased concentrations (55 g/L) of triglycerides in serum. Finally, we assessed the interference of carboxylesterase, an esterase that is released into the serum together with lipase in pancreatic disorders and which can cleave some lipase substrates. We added 130 000 U/L carboxylesterase to the reaction mixture and found no measurable lipase activity.
Measurement of pancreatic lipase activity in serum 367
Ann Clin Biochem 2001: 38 Figure 1 shows the correlation between the values obtained with the proposed method and the turbidimetric and coupled enzymatic methods in serum samples from unselected hospitalized patients with normal and increased lipase activities. As can be seen, the correlation coef®cients were good but the scatter of data was signi®cant. It should also be noted that, as the meaning/ de®nition of`units' for each of the employed methods is different, a slope of 1´00 should not be expected in the correlation.
Method comparison and commutability of control materials
To test for commutability,ten control materials were assayed in triplicate in parallel with the previous serum specimens and between-method relations of the control materials were compared with those of patients' serum samples. Materials were considered commutable if the ratio of lipase results obtained with two methods in control samples did not exceed 2 SD the mean ratio for patients' results. Results of this evaluation are shown in Table 2 . For the coupled enzymatic/ chromogenic methods, Merck and Roche materials were not commutable, whereas values for the turbidimetric/chromogenic methods were better.
Reference interval
After conditions for the method were established, the procedure was applied to the determination of pancreatic lipase activity in serum samples from 162 apparently healthy subjects. We then calculated the reference interval using non-parametric determination of percentiles. 20 The reference limits were estimated to be 6±38 U/L (95% central range). No sex-related (P=0´90) or agerelated (P=0´78) differences were detected.
DISCUSSION
The ever-increasing automation that now prevails in clinical laboratories calls for pancreatic lipase methods that can readily be adapted to automated instruments without loss of reliability. The kinetic colorimetric method described in this paper meets these requirements. The assay is rapid, having an analytical turnaround time of 54 min, and compares well with the widely established turbidimetric and coupled enzymatic methods, even if results of patients' catalytic activities differed with the procedures used, a fact that has often been reported. 6, 12, 13, 21 Commercial control materials were also investigated for their catalytic properties. Results indicated, with some exceptions, an inter-method behaviour of the examined materials similar to that of patients' specimens.
The key feature is the type of substrate used, which was a synthetic long-chain chromogen with two glycerol ether bonds and one ester bond. Manufacture of the substrate in the form of a stable microemulsion makes possible the production of an optically clear solution that is suitable for direct photometric measurement. However, substrates for lipase may also be hydrolysed by esterases, which are expressed in a variety of pancreatic and non-pancreatic tissues. Recently, results from Roche scientists, obtained from samples with high levels of esterase, showed that the speci®city of DGGR for pancreatic lipase compares well with that of the widely established turbidimetric method. 22 However, the number of patients studied was small and a larger clinical evaluation will be necessary.
In conclusion, our results qualify the present assay as an innovative approach to serum lipase analysis, offering signi®cant advantages with regard to convenience. Kinetic colorimetric monitoring, stability of`ready-to-use' reagent solutions and easy automation make it an attractive alternative to current methods for assaying serum lipase in clinical laboratories. 
